Literature DB >> 19373465

Systemic sclerosis in Sarawak: a profile of patients treated in the Sarawak General Hospital.

C L Teh1, Y C Kuan, J S Wong.   

Abstract

We performed a cross-sectional study of the demography, clinical and laboratory features of patients with systemic sclerosis patients followed up in our centre from 1984 to 2007. There were 23 cases with the majority of them (96%) being female. They have a mean age of 50.3 years and a mean disease duration of 6.02 (SD 5.82) years. Our patients comprised of multi-ethnic groups with predominantly Chinese (52%), Sarawak natives (35%) and Malays (13%). They have a mean lag time to diagnosis of 24.8 (SD 34.8) months. All the patients have sclerodermatous skin changes with 16(70%) having diffuse scleroderma and 7(30%) having limited scleroderma. The common clinical manifestations found in our patients were Raynaud's phenomenon (91%), sclerodactyly (65%), digital ulcers (52%) and pulmonary fibrosis (52%). There was low incidence of pulmonary hypertension (13%) and renal involvement (4%). The majority of our patients (67%) have positive ANA with 33% positive Scl-70. The majority received calcium channel blockers (87%), aspirin (48%) and low-dose prednisolone (48%). One patient developed adenocarcinoma of the lung on follow-up. This study demonstrated the rarity of systemic sclerosis in our centre with considerable lag time to diagnosis in our patients. Diffuse cutaneous systemic scleroderma is more common in our centre with rare pulmonary hypertension and renal involvement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373465     DOI: 10.1007/s00296-009-0938-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  4 in total

1.  Profile of systemic sclerosis in a tertiary care center in North India.

Authors:  Vinod K Sharma; Tejasvi Trilokraj; Binod K Khaitan; Sumanth M Krishna
Journal:  Indian J Dermatol Venereol Leprol       Date:  2006 Nov-Dec       Impact factor: 2.545

2.  Risk of malignancy in scleroderma: a population-based cohort study.

Authors:  Soumya Chatterjee; George W Dombi; Richard K Severson; Maureen D Mayes
Journal:  Arthritis Rheum       Date:  2005-08

Review 3.  Scleroderma epidemiology.

Authors:  Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

4.  Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre.

Authors:  L Pagalavan; S G Ong
Journal:  Med J Malaysia       Date:  2007-06
  4 in total
  4 in total

Review 1.  Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries.

Authors:  Michele Iudici; Serena Fasano; Daniela Iacono; Barbara Russo; Giovanna Cuomo; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2013-11-19       Impact factor: 2.980

2.  Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India.

Authors:  Sudip Kumar Ghosh; Debabrata Bandyopadhyay; Indranil Saha; Jayanta Kumar Barua
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

3.  Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Hariklia Dimitroula; Tilemahos Sfetsios; Despina Parcharidou; Haralambos Karvounis; Loukas Settas
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

4.  Systemic sclerosis with hemoptysis and a huge lung cavity.

Authors:  Attapon Cheepsattayakorn; Ruangrong Cheepsattayakorn
Journal:  Clin Pract       Date:  2011-11-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.